IL264576A - Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth - Google Patents

Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth

Info

Publication number
IL264576A
IL264576A IL264576A IL26457619A IL264576A IL 264576 A IL264576 A IL 264576A IL 264576 A IL264576 A IL 264576A IL 26457619 A IL26457619 A IL 26457619A IL 264576 A IL264576 A IL 264576A
Authority
IL
Israel
Prior art keywords
preterm
biomarkers
premature rupture
predicting
spontaneous labor
Prior art date
Application number
IL264576A
Other languages
English (en)
Hebrew (he)
Inventor
Durlin Edward Hickok
John Jay Boniface
Julja Burchard
Greg Charles Critchfield
Tracey Cristine Fleischer
Chien Hsu
Original Assignee
Sera Prognostics Inc
Durlin Edward Hickok
John Jay Boniface
Julja Burchard
Greg Charles Critchfield
Tracey Cristine Fleischer
Chien Hsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sera Prognostics Inc, Durlin Edward Hickok, John Jay Boniface, Julja Burchard, Greg Charles Critchfield, Tracey Cristine Fleischer, Chien Hsu filed Critical Sera Prognostics Inc
Publication of IL264576A publication Critical patent/IL264576A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL264576A 2016-08-05 2019-01-31 Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth IL264576A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662371666P 2016-08-05 2016-08-05
US201762449862P 2017-01-24 2017-01-24
PCT/US2017/045576 WO2018027171A1 (en) 2016-08-05 2017-08-04 Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor

Publications (1)

Publication Number Publication Date
IL264576A true IL264576A (en) 2019-02-28

Family

ID=61073085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264576A IL264576A (en) 2016-08-05 2019-01-31 Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth

Country Status (10)

Country Link
US (3) US20180172698A1 (cg-RX-API-DMAC7.html)
EP (1) EP3494233A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019532261A (cg-RX-API-DMAC7.html)
KR (1) KR20190046825A (cg-RX-API-DMAC7.html)
CN (1) CN110191963A (cg-RX-API-DMAC7.html)
AU (1) AU2017307584A1 (cg-RX-API-DMAC7.html)
CA (1) CA3032754A1 (cg-RX-API-DMAC7.html)
IL (1) IL264576A (cg-RX-API-DMAC7.html)
RU (1) RU2019105691A (cg-RX-API-DMAC7.html)
WO (1) WO2018027171A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2724013C2 (ru) 2015-06-19 2020-06-18 Сера Прогностикс, Инк. Пары биологических маркеров для предсказания преждевременных родов
EP3668996A4 (en) 2017-08-18 2021-04-21 Sera Prognostics, Inc. PREGNANCY CLOCK PROTEIN TO PREDICT THE EXPECTED DATE AND TIME OF BIRTH
JP2021501343A (ja) * 2017-10-30 2021-01-14 カーメンティクス・プロプライエタリー・リミテッド 早産のバイオマーカー
EP4165416A1 (en) * 2020-06-10 2023-04-19 Board of Regents, The University of Texas System Method for determining risk of pre-term birth
US20240013925A1 (en) * 2020-11-05 2024-01-11 Board Of Regents, The University Of Texas System Individual optimal mode of delivery
WO2022246288A2 (en) * 2021-05-21 2022-11-24 Sera Prognostics, Inc. Biomarker pairs and triplets for predicting preterm birth
RU2763707C1 (ru) * 2021-06-01 2021-12-30 Наталья Борисовна Кузнецова Способ прогнозирования преждевременного разрыва плодных оболочек в сроке от 22 до 28 недель беременности
US11664100B2 (en) 2021-08-17 2023-05-30 Birth Model, Inc. Predicting time to vaginal delivery
WO2023102786A1 (zh) * 2021-12-08 2023-06-15 深圳华大基因股份有限公司 基因标志物在预测孕妇早产风险中的应用
WO2024156709A1 (en) * 2023-01-24 2024-08-02 Université Clermont Auvergne Evaluation of serum cx3cl1 for the prediction of preterm premature rupture of membranes
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
RU2586412C2 (ru) * 2012-06-09 2016-06-10 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ оценки риска возникновения патологии беременности
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
WO2014110098A1 (en) * 2013-01-08 2014-07-17 Duke University Biomarkers for the prediction of preterm birth
EP2972393A4 (en) * 2013-03-15 2016-10-26 Sera Prognostics Inc BIOMARKERS AND METHOD FOR PREDICTING PREECLAMPSIA
US20140287948A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
EP3800470A1 (en) * 2013-03-15 2021-04-07 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
RU2724013C2 (ru) * 2015-06-19 2020-06-18 Сера Прогностикс, Инк. Пары биологических маркеров для предсказания преждевременных родов

Also Published As

Publication number Publication date
KR20190046825A (ko) 2019-05-07
EP3494233A4 (en) 2020-03-18
WO2018027171A1 (en) 2018-02-08
CN110191963A (zh) 2019-08-30
JP2019532261A (ja) 2019-11-07
US20210190792A1 (en) 2021-06-24
RU2019105691A (ru) 2020-09-08
CA3032754A1 (en) 2018-02-08
US20250085293A1 (en) 2025-03-13
US20180172698A1 (en) 2018-06-21
EP3494233A1 (en) 2019-06-12
JP2022140511A (ja) 2022-09-26
AU2017307584A1 (en) 2019-03-21

Similar Documents

Publication Publication Date Title
IL264576A (en) Biological markers for predicting preterm birth due to water loss before labor starts versus spontaneous preterm birth
IL286853A (en) Methods for diagnosing sepsis
IL256399A (en) Pairs of biomarkers for predicting premature birth
ZA201607414B (en) Method for dry reforming of at least one alkane
EP3368474A4 (en) ELECTROCHEMICAL GAS SEPARATION METHOD
GB201402293D0 (en) Biomarker signatures for the prediction of onset of sepsis
PL3256853T3 (pl) Przewidywanie epitopów komórek T przydatnych do szczepienia
ZA201704499B (en) Gammadelta t cell expansion procedure
SG11201609091YA (en) Method for assessing state of differentiation of cells
DK3785799T3 (da) Fremstillingsfremgangsmåder til vanddispergerbare assays
IL283015A (en) Identifying male fertility status by determining sperm quality
GB201403432D0 (en) Improved method for synthesis of composite membranes
IL274325A (en) Biomarkers for preterm birth
EP3494232A4 (en) BIOMARKERS FOR PREDICTING PREMATURE DELIVERY IN A GRAVID FEMALE EXPOSED TO PROGESTOGENS
NO20190593A1 (en) Prediction of methane hydrate production parameters
SG10201913138TA (en) Method for assessing a state of a living cell
EP3105353A4 (en) P13k-mtorc1-s6k1 signaling pathway biomarkers predictive of anti-cancer responses
EP3128326A4 (en) Biomarker for diagnosis of aging or amyotrophia
GB2557797B (en) Chemical means to predict end of job in reverse-circulation cementing
GB201704915D0 (en) Electrochemical corrosion of catalyst material for PCD elements
ME03552B (me) Novi kristalni oblici mononatrijumove soli foramsulfurona
GB2517004B (en) High-throughput mass-spectrometric characterization of samples
IL252944B (en) Granticin B polymorph
GB201511542D0 (en) Use of cell free nucleosomes as biomarkers
RU2015148228A (ru) Способ разделения зеотропной смеси бутилбутират - масляная кислота